TL;DR: A denied claim is a document problem dressed as a medical one. The payer's own policy specifies the criteria, the denial letter names a reason, and the appeal window is short — but almost nobody assembles the three into a filed appeal. The wedge is narrow and unglamorous: read the denial, match it against the plan's published policy, produce a citation-backed appeal, and track the deadline.
The evidence
PainHunt's healthcare domains hold 113 posts above the 10/15 threshold, averaging 11.1, with pain intensity 8.0/10 and willingness-to-pay 6.1/10 across 433 extracted pain points. Be explicit about where this comes from: Twitter and Bluesky supply 80 of those posts, with a smaller professional tail on remote job boards, Hacker News, Substack, and Mastodon. This is public frustration, not procurement intent, and it should be weighted accordingly.
What that frustration describes is consistent. Claim denials leave people feeling they have no recourse against a decision they cannot see the reasoning behind. There is no way to compare what a treatment will cost before receiving it, so cost is discovered after the fact. One account puts roughly $400 of out-of-pocket cost against ear drops for a simple ear infection, and the same cluster describes skipping treatment because of price — a risky health decision made on financial grounds.
The pattern is not confined to one system. A separate strand describes a life-extending cancer therapy rejected on cost grounds by a national health service, with patients left without an affordable route to a medication approved elsewhere, and no systematic way to coordinate an access campaign.
The feature requests are notably practical: automation to help patients fight denials, a cost-transparency tool for comparing prices across providers and plans, a patient advocacy platform for dealing with insurers and medical billing, prescription and procedure price comparison, and lower-cost telemedicine for minor complaints.
Why now
Denial volume and denial automation rose together. When adjudication is automated, denials arrive faster and in higher volume, and their stated reasons become more formulaic — which cuts both ways. A formulaic denial is dispiriting to receive and considerably easier to answer systematically than a hand-written one.
The raw material for a rebuttal is also more available than it used to be. Plan documents, coverage policies, and medical necessity criteria are published, and in several jurisdictions price transparency rules require machine-readable rate files. The inputs for a grounded appeal exist in public; what is missing is the assembly.
And the modern LLM stack is a genuinely good fit for exactly this task — reading a denial letter, locating the governing clause, and drafting a letter in the format the payer expects. That is retrieval and templating against a fixed corpus, which is the one thing this technology can be made reliable at, provided every claim in the output is cited.
The wedge
One document, one deadline, one filed appeal.
- Start at the denial letter. The user uploads it. Extract the payer, plan, denial code and stated reason, service date, and appeal deadline. That extraction alone — "you have 41 days left and this is a medical-necessity denial" — is more than most patients have today.
- Ground every argument in the plan's own policy. Retrieve the applicable coverage policy and quote it. An appeal that cites the payer's published criteria is a different object from a letter that argues in general terms, and the citation requirement is also what keeps the model honest.
- Run the clock and follow through. Track the deadline, generate the submission in the payer's required channel, and prompt for the second-level appeal or external review when the first is refused. Completion is the value; drafting is the easy part.
- Publish outcome data as it accumulates. Anonymised overturn rates by payer and denial type would be genuinely new public information, and it is the strongest marketing this product could have. It is also a reason for a patient to try an appeal they had written off.
Pick one payer market and one or two denial types — medical necessity and out-of-network are the volume categories — before generalising. Distribution sits with patient advocates, condition-specific communities, and the billing staff of small practices who watch the same denials arrive weekly.
Risks and honest caveats
- This is regulated territory and the boundaries are real. Handling clinical records means health-privacy obligations, and preparing appeals on someone's behalf can shade into regulated advocacy depending on jurisdiction. Get this reviewed before writing code, not before launching.
- Willingness to pay is the lowest in this batch, at 6.1/10. The people hurt most are the ones least able to pay, which is a hard commercial fact and not a solvable branding problem. Realistic payers are employers, patient-advocacy organisations, and provider billing teams — the patient may need to be the user rather than the customer.
- Never promise an overturn. You do not control the decision. Selling an outcome you cannot deliver in a medical context is both a refund liability and a serious ethical problem when the customer is sick.
- A wrong citation is worse than no product. A confidently fabricated policy reference in a medical appeal could cost someone care. Refusal on low confidence must be the default, and every quoted clause must resolve to a retrievable document.
- The social-media source mix is a genuine weakness in this signal. Public anger about healthcare costs is abundant and does not imply anyone will buy software. Before building, go find twenty people who have actually filed an appeal and ask what stopped them — that conversation, not this data set, is what should decide it.
How to validate this further
Browse the healthcare and insurance threads in the Pain Point Browser, then pressure-test the appeal-automation framing with the Idea Validator. Related reading: safety guardrails for AI in health and legal contexts and a verification layer for AI output.